Summary of Key Findings
A team from Yale University analyzed 51 human anti-aging interventions and 16 epigenetic clocks by establishing the large TranslAGE database, reaching several key conclusions:
- Not all epigenetic clocks are reliable; the newer generation of “death clocks” and “speed clocks” are more accurate.
- Drug interventions (such as anti-TNF therapies and metformin) are more effective than lifestyle changes or supplements.
- The anti-aging effects are significantly better in patients compared to healthy individuals.
- The newer generation of clocks can accurately identify which organs are aging and can be improved.
- The effects of some so-called “miracle drugs” (such as those that eliminate senescent cells) are inconsistent.
This study has established a standardized evaluation system for the anti-aging field, facilitating the transition of epigenetic clocks from the laboratory to clinical applications.
Detailed Interpretation
1. Epigenetic Clocks: Choose the Right Tool to Avoid Misleading Results
Epigenetic clocks are like the “smart odometers” of our bodies—by examining methylation patterns on DNA (similar to tree ring patterns), they can quickly assess our biological age, aging rate, or risk of death. However, not all clocks are accurate:
- The newer generation is more sensitive: For example, DunedinPACE (which measures aging rate) could detect a slowdown in aging in 16 interventions, while PCGrimAge (which predicts risk of death) provided the most stable results.
- The first generation of clocks was less accurate: Older clocks that only measured biological age showed erratic results, making it difficult to determine the effects of interventions.
In simple terms: To determine the effectiveness of anti-aging methods, use “death risk clocks” or “aging rate clocks” rather than just age-based clocks.
2. Medications Outperform Supplements
The study categorized interventions into four categories, with clear differences in effectiveness:
- Medication interventions are the most effective: Anti-TNF therapies (used to treat rheumatoid arthritis) and metformin (an old diabetes drug) significantly changed multiple clock readings and showed the most stable results.
- Lifestyle changes are less effective: A Mediterranean diet can reduce epigenetic age, but not as much as medications.
- Supplements and medical procedures are less effective: Supplements like fish oil and folic acid had little effect, and procedures like hyperbaric oxygen and gene therapy had unclear outcomes.
In simple terms: Taking supplements is less effective than taking medications for anti-aging (of course, always follow medical advice); dietary adjustments can only provide additional support.
3. The More Diseased, the More Obvious the Effects; Healthy People Show Fewer Changes
This may seem counterintuitive, but it makes sense: People with chronic inflammation or metabolic diseases experience a much greater reduction in epigenetic age after anti-aging interventions compared to healthy individuals.
The reason is simple: Healthy bodies are already in good condition and have less room for improvement; whereas diseased bodies are in a state of imbalance, so improvements are more noticeable.
Implication: Future anti-aging trials should focus on high-risk groups (such as those with diabetes or arthritis) to see results more quickly.
4. The New Generation of Clocks Can Identify Specific Organs That Are Improving
Traditional clocks can only indicate whether you are younger or older; the new generation of “interpretable clocks” can specify which organs are benefiting:
- Quitting smoking → Improvement in the lung system.
- Metformin → Comprehensive improvement in inflammation, brain, and metabolic systems.
- Hyperbaric oxygen → Improvement in the lungs and musculoskeletal system.
- A vegan diet → Improvement in inflammation and musculoskeletal health.
Value: This opens the door to developing targeted anti-aging therapies—for example, people with lung aging could be advised to quit smoking or undergo hyperbaric oxygen therapy; those with metabolic issues might benefit more from metformin.
5. Some “Miracle Drugs” Are Inconsistent in Their Effects
The study found that some widely promoted anti-aging methods (such as senolytic drugs that eliminate senescent cells) produced contradictory results. In the same trial, some clocks showed aging, while others showed rejuvenation; in different studies, the same clock could yield opposite outcomes.
Caution: Be skeptical of sensational anti-aging claims; a single study is not enough; multiple studies are needed for confirmation.
Limitations and Future Directions of the Study
While the results are significant, three issues remain unresolved:
1. Whether short-term changes in epigenetic age truly translate into longer lifespan or fewer illnesses.
2. The varying designs of the studies make it difficult to establish a clear causal relationship between interventions and improved health.
3. How much change in epigenetic age is considered meaningful? More data is needed to link clock changes to actual health outcomes (such as heart disease rates or memory decline).
Nevertheless, the biggest contribution of this study is the establishment of a standardized evaluation system. In the future, when you see claims about products reversing aging, you can ask: Which clock was used? Were the tests conducted on patients or healthy individuals? Have the results been replicated?
With the expansion of the database and more clinical trials, we are one step closer to developing truly quantifiable anti-aging therapies.
(End of article)
Paper link: https://www.nature.com/articles/s41591-026-04562-9